We are live on ! Find out more
AACR

ACR Alpine Capital Research Portfolio holdings

AUM $6.7B
1-Year Est. Return 33.44%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+33.44%
3 Year Est. Return
+61.38%
5 Year Est. Return
+53.14%
10 Year Est. Return
+201.58%
AUM
$654M
AUM Growth
+$53.1M
Cap. Flow
+$36.2M
Cap. Flow %
5.54%
Top 10 Hldgs %
89.98%
Holding
28
New
1
Increased
10
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
RFP
Resolute Forest Products Inc.
RFP
+$21.8M
2
VOD icon
Vodafone
VOD
+$18.7M
3
JPM icon
JPMorgan Chase
JPM
+$4.25M
4
WMT icon
Walmart Inc
WMT
+$3.92M
5
MSFT icon
Microsoft
MSFT
+$3.34M

Top Sells

Rank Stock Value
1
ITW icon
Illinois Tool Works
ITW
+$21.4M
2
MRK icon
Merck
MRK
+$952K
3
LMT icon
Lockheed Martin
LMT
+$583K
4
NWL icon
Newell Brands
NWL
+$298K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$273K

Sector Composition

Rank Sector Weight
1 Healthcare 30.17%
2 Technology 20.82%
3 Consumer Staples 15.72%
4 Financials 14.48%
5 Communication Services 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
1
Humana
HUM
$47B
$72.3M 11.07%
566,447
+13,888
+3% +$1.64M
INTC icon
2
Intel
INTC
$501B
$69M 10.55%
2,231,999
+77,850
+4% +$2.13M
MSFT icon
3
Microsoft
MSFT
$2.83T
$67.1M 10.27%
1,609,939
+82,473
+5% +$3.34M
JNJ icon
4
Johnson & Johnson
JNJ
$624B
$66M 10.09%
630,494
+15,011
+2% +$1.52M
JPM icon
5
JPMorgan Chase
JPM
$926B
$61.3M 9.38%
1,064,340
+75,644
+8% +$4.25M
SYY icon
6
Sysco
SYY
$38.9B
$59.1M 9.04%
1,576,982
+70,686
+5% +$2.6M
MRK icon
7
Merck
MRK
$322B
$58.5M 8.95%
1,060,121
-17,456
-2% -$952K
VOD icon
8
Vodafone
VOD
$35.3B
$55.6M 8.51%
1,665,350
+529,450
+47% +$18.7M
WMT icon
9
Walmart Inc
WMT
$860B
$43.5M 6.65%
1,736,595
+152,784
+10% +$3.92M
RFP
10
DELISTED
Resolute Forest Products Inc.
RFP
$35.7M 5.46%
2,126,403
+1,317,055
+163% +$21.8M
BRK.B icon
11
Berkshire Hathaway Class B
BRK.B
$1.06T
$31.9M 4.89%
252,422
-2,153
-0.8% -$273K
LMT icon
12
Lockheed Martin
LMT
$131B
$28.3M 4.33%
175,955
-3,588
-2% -$583K
VTI icon
13
Vanguard Total Stock Market ETF
VTI
$652B
$1.01M 0.15%
9,943
+81
+0.8% +$7.98K
JPM.WS
14
DELISTED
JPMorgan Chase
JPM.WS
$812K 0.12%
42,000
– –
BSV icon
15
Vanguard Short-Term Bond ETF
BSV
$44.5B
$634K 0.1%
7,888
– –
MET icon
16
MetLife
MET
$59.6B
$361K 0.06%
7,293
– –
NSC icon
17
Norfolk Southern
NSC
$77.7B
$361K 0.06%
3,500
– –
TEVA icon
18
Teva Pharmaceuticals
TEVA
$36B
$351K 0.05%
6,700
– –
SMBC icon
19
Southern Missouri Bancorp
SMBC
$847M
$303K 0.05%
17,000
– –
C icon
20
Citigroup
C
$221B
$268K 0.04%
5,700
– –
PG icon
21
Procter & Gamble
PG
$341B
$245K 0.04%
3,119
-64
-2% -$5.16K
NAVI icon
22
Navient
NAVI
$795M
$197K 0.03%
+11,120
New +$184K
KINS icon
23
Kingstone Companies
KINS
$275M
$167K 0.03%
25,000
– –
SLM icon
24
SLM Corp
SLM
$4.62B
$92K 0.01%
11,120
-19,994
-64% -$176K
F icon
25
Ford
F
$56B
$90K 0.01%
5,200
-14,500
-74% -$236K
1
2

Similar funds

MSE
MUFG Securities EMEA London, United Kingdom $6.7B AUM 32.3% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
BHM
Briar Hall Management Nashville, Tennessee $6.72B AUM 4.95% 1-Year Est. Return
SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
TB
Thoma Bravo Chicago, Illinois $6.65B AUM 29.42% 1-Year Est. Return

ACR Alpine Capital Research's Q2 2014 Portfolio in Review

As of Q2 2014, ACR Alpine Capital Research held 28 positions worth $654M, up 8.8% from $600M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

ACR Alpine Capital Research deployed $36.2M of net new capital in Q2 2014, opening 1 new position and adding to 10 existing holdings. Its largest new stake was Navient: 11,120 shares worth $197K.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 30% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Merck, an estimated $952K trimmed.

  • ACR Alpine Capital Research's largest Q2 2014 buy was Navient: 11,120 shares worth $197K.
  • ACR Alpine Capital Research added most to Resolute Forest Products Inc. in Q2 2014, an estimated $21.8M increase.
  • ACR Alpine Capital Research's biggest Q2 2014 reduction was Merck, cutting an estimated $952K.
  • ACR Alpine Capital Research fully exited Illinois Tool Works in Q2 2014, selling an estimated $21.4M.
  • ACR Alpine Capital Research's ten largest holdings make up 90% of its $654M portfolio in Q2 2014.
  • ACR Alpine Capital Research opened 1 new position and closed 2 in Q2 2014.
  • ACR Alpine Capital Research's portfolio value rose 8.8% quarter-over-quarter to $654M.

Based on ACR Alpine Capital Research's 13F filing for Q2 2014, filed 14 Aug 2014.